Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001477932-19-005299
Filing Date
2019-09-09
Accepted
2019-09-06 19:00:15
Documents
10
Period of Report
2019-09-06

Document Format Files

Seq Description Document Type Size
1 FORM 6-K pvotf_6k.htm 6-K 7334
2 MATERIAL CHANGE REPORT pvotf_ex991.htm EX-99.1 46027
3 pvotf_ex991img1.jpg GRAPHIC 14551
4 pvotf_ex992img1.jpg GRAPHIC 14618
5 pvotf_ex993img1.jpg GRAPHIC 14764
6 pvotf_ex993img2.jpg GRAPHIC 14764
7 pvotf_ex993img3.jpg GRAPHIC 14764
8 pvotf_ex994img1.jpg GRAPHIC 14764
9 pvotf_ex994img2.jpg GRAPHIC 14911
10 pvotf_ex994img3.jpg GRAPHIC 14911
  Complete submission text file 0001477932-19-005299.txt   218121
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 514-943-1899
Pivot Pharmaceuticals Inc. (Filer) CIK: 0001464165 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0131
Type: 6-K | Act: 34 | File No.: 333-161157 | Film No.: 191080588
SIC: 2834 Pharmaceutical Preparations